Back
NLS Pharmaceutics Stock Price Chart

Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
62
NLSP
NLS Pharmaceutics
Last Price:
$2.17
Seasonality Move:
-17.66%
7 Day Trial
ALL ACCESS PASS
$
7

Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLSP is experiencing slight selling pressure.
NLS Pharmaceutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.02 | Buy |
20-day SMA: | 1.8 | Buy |
50-day SMA: | 1.6 | Buy |
200-day SMA: | 3.05 | Sell |
8-day EMA: | 2.07 | Buy |
20-day EMA: | 1.86 | Buy |
50-day EMA: | 1.75 | Buy |
200-day EMA: | 3.9 | Sell |
NLS Pharmaceutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 69.4 | Buy |
Chaikin Money Flow: | -59474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.5 - 1.98) | Buy |
Bollinger Bands (100): | (1.47 - 2.07) | Buy |
NLS Pharmaceutics Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NLS Pharmaceutics Stock
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 2.20 while NLSP 8-day simple moving average is 2.02, which is a Buy signal.
-
The stock price of NLSP is 2.20 while NLS Pharmaceutics 20-day SMA is 1.80, which makes it a Buy.
-
NLS Pharmaceutics 50-day simple moving average is 1.60 while NLSP share price is 2.20, making it a Buy technically.
-
NLSP stock price is 2.20 and NLS Pharmaceutics 200-day simple moving average is 3.05, creating a Sell signal.
NLSP Technical Analysis vs Fundamental Analysis
Buy
62
NLS Pharmaceutics (NLSP)
is a Buy
Is NLS Pharmaceutics a Buy or a Sell?
-
NLS Pharmaceutics stock is rated a BuyThe current NLS Pharmaceutics [NLSP] share price is $2.20. The Score for NLSP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
NLS Pharmaceutics Stock Info
Market Cap:
9.9M
Price in USD:
2.20
Share Volume:
118.9K
NLS Pharmaceutics 52-Week Range
52-Week High:
18.39
52-Week Low:
1.30
Buy
62
NLS Pharmaceutics (NLSP)
is a Buy
NLS Pharmaceutics Share Price Forecast
-
What is the NLS Pharmaceutics stock price today?The NLS Pharmaceutics stock price is 2.20 USD today.
-
Will NLSP stock go up or go down?NLS Pharmaceutics> share price is forecast to RISE/FALL based on technical indicators
-
Is NLS Pharmaceutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NLS Pharmaceutics is not overvalued.
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 2.20 while NLSP 8-day exponential moving average is 2.07, which is a Buy signal.
-
The stock price of NLSP is 2.20 while NLS Pharmaceutics 20-day EMA is 1.86, which makes it a Buy.
-
NLS Pharmaceutics 50-day exponential moving average is 1.75 while NLSP share price is 2.20, making it a Buy technically.
-
NLSP stock price is 2.20 and NLS Pharmaceutics 200-day simple moving average is 3.90, creating a Sell signal.
Technical Analysis of NLS Pharmaceutics
Should I short NLS Pharmaceutics stock?
-
NLSP Moving Average Covergence Divergence (MACD) indicator is 0.17, suggesting NLS Pharmaceutics is a Buy
-
NLS Pharmaceutics Relative Strength Index (RSI) is 69.4, which suggest NLS Pharmaceutics is overbought
-
The Bollinger Bands (25) for NLS Pharmaceutics is (1.5 - 1.98), which suggest NLS Pharmaceutics is a Buy
-
The Bollinger Bands (100) for NLS Pharmaceutics is (1.47 - 2.07), which suggest NLS Pharmaceutics is a Buy
* NLS Pharmaceutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.